Search details
1.
Dose-dense therapy improves survival in aggressive non-Hodgkin's lymphoma.
Ann Hematol
; 89(3): 273-82, 2010 Mar.
Article
in English
| MEDLINE | ID: mdl-19693500
2.
Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy.
Clin Cancer Res
; 14(7): 2082-7, 2008 Apr 01.
Article
in English
| MEDLINE | ID: mdl-18381948
3.
Up-front tandem high-dose chemotherapy compared with standard chemotherapy with doxorubicin and paclitaxel in metastatic breast cancer: results of a randomized trial.
J Clin Oncol
; 23(3): 432-40, 2005 Jan 20.
Article
in English
| MEDLINE | ID: mdl-15659490
4.
Clinical role of multidrug resistance protein 1 expression in chemotherapy resistance in early-stage breast cancer: the Austrian Breast and Colorectal Cancer Study Group.
J Clin Oncol
; 23(6): 1161-8, 2005 Feb 20.
Article
in English
| MEDLINE | ID: mdl-15718312
5.
High p27Kip1 expression predicts superior relapse-free and overall survival for premenopausal women with early-stage breast cancer receiving adjuvant treatment with tamoxifen plus goserelin.
J Clin Oncol
; 21(19): 3594-600, 2003 Oct 01.
Article
in English
| MEDLINE | ID: mdl-14512390
6.
Randomized adjuvant trial of tamoxifen and goserelin versus cyclophosphamide, methotrexate, and fluorouracil: evidence for the superiority of treatment with endocrine blockade in premenopausal patients with hormone-responsive breast cancer--Austrian Breast and Colorectal Cancer Study Group Trial 5.
J Clin Oncol
; 20(24): 4621-7, 2002 Dec 15.
Article
in English
| MEDLINE | ID: mdl-12488405
7.
Randomized trial of tamoxifen versus tamoxifen plus aminoglutethimide as adjuvant treatment in postmenopausal breast cancer patients with hormone receptor-positive disease: Austrian breast and colorectal cancer study group trial 6.
J Clin Oncol
; 21(6): 984-90, 2003 Mar 15.
Article
in English
| MEDLINE | ID: mdl-12637461
8.
Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer.
Clin Cancer Res
; 8(6): 1831-7, 2002 Jun.
Article
in English
| MEDLINE | ID: mdl-12060624
9.
Zoledronic acid prevents cancer treatment-induced bone loss in premenopausal women receiving adjuvant endocrine therapy for hormone-responsive breast cancer: a report from the Austrian Breast and Colorectal Cancer Study Group.
J Clin Oncol
; 25(7): 820-8, 2007 Mar 01.
Article
in English
| MEDLINE | ID: mdl-17159195
10.
Long-term results of dose density therapy in patients with aggressive lymphoma.
Ann Hematol
; 84(4): 217-22, 2005 Apr.
Article
in English
| MEDLINE | ID: mdl-15538568
11.
Long-term results of autologous stem cell transplantation for Hodgkin's disease (HD) and low-/intermediate-grade B non-Hodgkin's lymphoma (NHL): a report from the Austrian Stem Cell Transplantation Registry (ASCTR).
Ann Hematol
; 84(7): 462-73, 2005 Jul.
Article
in English
| MEDLINE | ID: mdl-15726362
12.
Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer.
Ann Surg
; 240(2): 306-12, 2004 Aug.
Article
in English
| MEDLINE | ID: mdl-15273556
13.
Gemcitabine combined with epirubicin in the treatment of patients with locally advanced or metastatic breast cancer: a phase II study.
Am J Clin Oncol
; 27(4): 429-35, 2004 Aug.
Article
in English
| MEDLINE | ID: mdl-15289740
14.
Significant increase in breast conservation in 16 years of trials conducted by the Austrian Breast & Colorectal Cancer Study Group.
Ann Surg
; 237(4): 556-64, 2003 Apr.
Article
in English
| MEDLINE | ID: mdl-12677153
Results
1 -
14
de 14
1
Next >
>>